Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
AI use in schools: How districts are making sure it's used as a study aid
Recommended
What to know about Labor Day and its history
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novamind Inc
(OP:
NVMDF
)
N/A
UNCHANGED
Last Price
Updated: 3:36 PM EDT, Jun 13, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Novamind Inc
< Previous
1
2
Next >
Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies
December 16, 2021
Palm Beach, FL –December 16, 2021 – FinancialNewsMedia.com News Commentary – Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing...
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Novamind Opens New Clinic with Specialized Focus on Substance Use Disorders
December 06, 2021
Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza TORONTO, ON / ACCESSWIRE / December 6, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the...
From
Novamind Inc.
Via
AccessWire
Topics
Death
Exposures
COVID-19
Death
Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6
December 02, 2021
TORONTO, ON / ACCESSWIRE / December 2, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will...
From
Novamind Inc.
Via
AccessWire
Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network
December 01, 2021
Strategic investment and advisory agreement enables the global expansion of Novamind's psychedelic clinic model TORONTO, ON / ACCESSWIRE / December 1, 2021 / Novamind Inc....
From
Novamind Inc.
Via
AccessWire
Novamind Reports Fiscal Q1 Financial Results and Operating Highlights
November 29, 2021
- Multistate expansion underway, signed LOI to acquire Arizona-based mental health practice - Total revenue of $1,857,750, +113% when compared to same period last year - Total working capital of...
From
Novamind Inc.
Via
AccessWire
Novamind Unveils New Logo and Invests in Unified Brand
November 24, 2021
TORONTO, ON / ACCESSWIRE / November 24, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today...
From
Novamind Inc
Via
AccessWire
Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona
November 16, 2021
TORONTO, ON / ACCESSWIRE / November 16, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today...
From
Novamind Inc.
Via
AccessWire
Novamind to Present at International Summit on Psychedelic Therapies for Mental Illness
November 15, 2021
TORONTO, ON / ACCESSWIRE / November 15, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will...
From
Novamind Ventures Inc.
Via
AccessWire
Novamind Enters New Lease Agreement Responding to Patient Demand
November 12, 2021
TORONTO, ON / ACCESSWIRE / November 12, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced...
From
Novamind Inc.
Via
AccessWire
Novamind Secures Insurance Coverage for Ketamine from Four Major Payors
November 10, 2021
Blue Cross added to list of insurance companies covering IV ketamine treatments at Novamind TORONTO, ON / ACCESSWIRE / November 10, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or...
From
Novamind Inc.
Via
AccessWire
Exposures
Product Safety
Novamind Announces Revocation of Cease Trade Order and Reinstatement of Trading
November 08, 2021
TORONTO, ON / ACCESSWIRE / November 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announces...
From
Novamind Inc.
Via
AccessWire
Novamind Reports FY2021 Financial Results and Operating Highlights
November 05, 2021
- Industry-leading revenue, $6,069,247 in FY2021 - Total working capital of $9,680,431 to fund operations - Expanded network to six clinics and three clinical research sites - Contracted for eight...
From
Novamind Inc.
Via
AccessWire
Exposures
COVID-19
Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements
November 04, 2021
TORONTO, ON / ACCESSWIRE / November 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today...
From
Novamind Inc.
Via
AccessWire
Novamind Unveils Stealth Mode Investment in Alto Neuroscience
October 22, 2021
TORONTO, ON / ACCESSWIRE / October 22, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased...
From
Novamind Ventures Inc.
Via
AccessWire
Novamind Granted DEA Licenses for Psilocybin Research
October 13, 2021
Licenses a key step in hosting contracted clinical trials for Schedule 1 controlled substances TORONTO, ON / ACCESSWIRE / October 13, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or...
From
Novamind Inc.
Via
AccessWire
Novamind to Present at LD Micro and KCSA Conferences
October 08, 2021
TORONTO, ON / ACCESSWIRE / October 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today...
From
Novamind Inc.
Via
AccessWire
Novamind Launches New Psychedelic Palliative Care Program
October 07, 2021
Specialized program to research and scale access to psychedelic medicine opens new doors for patients with chronic and serious illness TORONTO, ON / ACCESSWIRE / October 7, 2021 / Novamind Inc....
From
Novamind Inc.
Via
AccessWire
Novamind to Deliver Keynote at PSYCH Investor Summit on October 7, 2021
October 04, 2021
Chief Medical Officer will join expert panel on data and tech in psychedelic-assisted psychotherapy TORONTO, ON / ACCESSWIRE / October 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"...
From
Novamind Ventures Inc.
Via
AccessWire
Novamind Opens 6th Integrative Psychiatry Clinic, Adds 3rd Clinical Research Site
September 30, 2021
TORONTO, ON / ACCESSWIRE / September 30, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is...
From
Novamind Inc.
Via
AccessWire
Novamind Announces DTC Eligibility for its Common Shares
September 24, 2021
TORONTO, ON / ACCESSWIRE / September 24, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is...
From
Novamind Inc.
Via
AccessWire
Novamind to Present at Benzinga Healthcare Conference
September 23, 2021
Novamind to be featured in panel discussion on the disruptive potential of psychedelic medicine in mental healthcare TORONTO, ON / ACCESSWIRE / September 23, 2021 / Novamind Inc....
From
Novamind Inc.
Via
AccessWire
Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF
September 20, 2021
TORONTO, ON / ACCESSWIRE / September 20, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is...
From
Novamind Inc.
Via
AccessWire
Novamind to Present at Life Sciences Investor Forum
September 14, 2021
TORONTO, ON / ACCESSWIRE / September 14, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is...
From
Novamind Inc.
Via
AccessWire
Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial
September 13, 2021
Cedar Clinical Research to Host Phase III Trial for Investigational Therapy for Schizophrenia TORONTO, ON / ACCESSWIRE / September 13, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or...
From
Novamind Inc.
Via
AccessWire
Novamind Uplists to OTCQB Venture Market
September 09, 2021
TORONTO, ON / ACCESSWIRE / September 9, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is...
From
Novamind Ventures Inc.
Via
AccessWire
Novamind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 08, 2021
TORONTO, ON / ACCESSWIRE / September 8, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is...
From
Novamind Inc.
Via
AccessWire
Novamind Divests Non-Core Retreat Investment
August 11, 2021
TORONTO, ON / ACCESSWIRE / August 11, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today...
From
Novamind Inc.
Via
AccessWire
Novamind Strengthens Mental Health Expertise, Adds Communications Leader
August 06, 2021
Samantha DeLenardo joins from CAMH, Canada's largest mental health teaching hospital and leader in mental health research TORONTO, ON / ACCESSWIRE / August 6, 2021 / Novamind Inc., (CSE:NM)(OTC...
From
Novamind Inc.
Via
AccessWire
Exposures
COVID-19
Novamind Opens 5th Clinic Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions
July 29, 2021
Company executes organic growth mandate, on track to open four new clinics by Q3 2021 TORONTO, ON / ACCESSWIRE / July 29, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the...
From
Novamind Inc.
Via
AccessWire
Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States
July 21, 2021
Aims to increase visibility and facilitate investment for United States investors TORONTO, ON / ACCESSWIRE / July 21, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the...
From
Novamind Inc.
Via
AccessWire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.